Se connecter Inscription gratuite

4SC AG Marge opérationnelle

Quel est le Marge opérationnelle de 4SC AG?

Le Marge opérationnelle de 4SC AG est -868.61%

Quelle est la définition de Marge opérationnelle?



La marge opérationnelle est le ratio du résultat opérationnel divisé par les ventes nettes et présenté en pourcentage.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Marge opérationnelle des entreprises dans Health Care secteur sur XETRA par rapport à 4SC AG

Que fait 4SC AG?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Entreprises avec marge opérationnelle similaire à 4SC AG